Researchers have taken an important first step towards finding a better treatment for T-cell acute lymphocytic leukemia 1 type, a severe form of childhood leukemia. In the quest for finding a better drug, researchers have uncovered a weak spot that triggers this aggressive form of childhood cancer, and have also identified a possible new treatment that exploits this vulnerability.